DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding DiaMedica Therapeutics Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 40 | 2 | 45 | +7 |
| Shares | 5.58M | 13.6K | 6.73M | +1.16M (+20.9%) |
| Value | $23.3M | $56.9K | $36.5M | +$13.3M (+57.0%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 683 Capital Management, LLC | 76,116 | $413.3K | 0.04% |
| Goldman Sachs Group Inc | 68,948 | $374.4K | 0.00% |
| Jane Street Group, LLC | 42,212 | $229.2K | 0.00% |
| Barclays PLC | 27,726 | $150.6K | 0.00% |
| Meridian Wealth Management, LLC | 27,216 | $147.8K | 0.01% |
| Schonfeld Strategic Advisors LLC | 26,097 | $141.7K | 0.00% |
| Omers Administration Corp | 22,500 | $122.2K | 0.00% |
| Pensionmark Financial Group, LLC | 21,915 | $119.0K | 0.00% |
| Bank of Montreal | 15,560 | $84.5K | 0.00% |
| Raymond James Financial Inc | 15,267 | $82.9K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 14,973 | $81.3K | 0.01% |
| Balyasny Asset Management LLC | 14,581 | $79.2K | 0.00% |
Sold out (5)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Point72 Asia (Singapore) Pte. Ltd. | 9,498 | $39.8K |
| Simplex Trading, LLC | 3,662 | $15.0K |
| Cubist Systematic Strategies, LLC | 3,263 | $13.7K |
| Tower Research Capital LLC (TRC) | 1,118 | $4.68K |
| JPMorgan Chase & Co | 27 | $113 |
Not filed for Q4 2024 yet (2)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 11,520 | $48.3K |
| Naples Money Management LLC | 2,068 | $8.66K |